Medicare Analysis Shows Savings From Multiple Sclerosis Treatment
Using Medicare claims data from 2006-2016, the researchers looked at trends in multiple sclerosisdrugprices over time. Not only did they find steep increases in list prices—the starting point before rebates, coupons or insurance kicks in—but also in the ultimate costs to both Medicare and its...
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research. Despite recent efforts to constrain escalatingcosts, researchers with OHSU and the OH...
I was starting my annual multiple sclerosis (MS) checkup with my neurologist, and before I met with her, I got this question from her MS nurse. I was stumped. I’d never been asked that before. I think most people with MS… June 10, 2022 Columns by John Connor My Right Arm Is...
Medicare plans accuse Teva of covering copays for patients A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost ...
Although the global rate of multiple sclerosis (MS) is low, a few studies have documented high costs. Costs are highly variable depending on MS stage. This study was designed to assess the economic burden of Medicare-eligible patients by MS type in the United States using a claims-based clas...
"Multiple Sclerosis: Your Legal Rights, 3rd Edition" enables readers to plan for the future and face tough decisions, such as: Can I return to work without compromising my Social Security disability benefits in the long term? How does the expansion of Medicare Part D affect me? And is ...
Patients covered by federal or state healthcare programs, including Medicare and Medicaid, are not eligible for assistance. This program is open to residents of the U.S. and U.S. territories with relapsing forms of multiple sclerosis who are starting or presently taking EMD Serono RMS product(...
NeuroVoices: Fred Lublin, MD, on Shifting From Phenotypes to Spectrum-Based Perspectives to Advance Multiple Sclerosis Care ByFred Lublin, MD Isabella Ciccone, MPH January 8th 2025 Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision ...
Greater access to community health centers may improve outcomes for Medicaid recipients and adults without insurance who have end-stage kidney disease, data show. Amid systematic barriers in health care, “nephrology is unique in that U.S. federal health insurance, Medicare, covers most patients wit...